Return to Home

Syneos Health, Inc.

SYNH

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
September 25, 2023

Days Left:
-240

calendar

Syneos Health, Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Allegations

The filed complaint alleges that defendants made false statements and/or concealed that: (a) Syneos’s business development capabilities had been materially impaired by workforce reductions and leadership and operational changes, as well as labor force turmoil caused by the COVID-19 pandemic; (b) Syneos had struggled to integrate recent acquisitions, causing the Company to suffer from a bloated and confused organizational structure and impairing the Company’s ability to provide comprehensive or effective customer engagement across its product portfolio; (c) Syneos was suffering from acute competitive disadvantages as clinical trials moved to remote monitoring and decentralized administration, as the Company lacked the tools possessed by some of its rivals to successfully run remote and decentralized trials, such as certain data visualization and statistical modeling capabilities, and the Company had failed to adapt to changing business demands in the wake of the COVID-19 pandemic; (d) Syneos’s backlog, book-to-bill ratios, and net new business awards had been artificially inflated by more than $500 million through the inclusion of reimbursable expenses that the Company would never collect; (e) as a result of (a)-(d) above, Syneos was struggling to execute on its existing contracts and to agilely respond to its client needs, causing the Company to suffer client dissatisfaction across its client base; and (f) as a result of (a)-(e) above, Syneos was exposed to a material undisclosed risk that the Company would lose customers, be unable to grow its client base or win significant contract renewals, and cede market share to its rivals.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Syneos purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Syneos during the relevant time frame, you have until September 25, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Find More Cases

Ticker Symbol Company Name Join Deadline
EVLV Evolv Technologies Holdings, Inc. May 24, 2024 Join
BLUE bluebird bio, Inc. May 28, 2024 Join
LUNA Luna Innovations Incorporated May 31, 2024 Join
HRT HireRight Holdings Corporation June 03, 2024 Join
VFS VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. June 11, 2024 Join
QDEL QuidelOrtho Corporation f/k/a Quidel Corporation June 11, 2024 Join
PERI Perion Network Ltd. June 17, 2024 Join
ASTS AST SpaceMobile, Inc. June 17, 2024 Join
RIVN Rivian Automotive, Inc. June 18, 2024 Join
SHCR Sharecare, Inc. June 18, 2024 Join
SHCR Sharecare, Inc. June 18, 2024 Join
GDRX GoodRx Holdings, Inc. June 21, 2024 Join
LNC Lincoln National Corporation June 24, 2024 Join
CMP Compass Minerals International, Inc. June 24, 2024 Join
ADSK Autodesk, Inc. June 24, 2024 Join
AKRO Akero Therapeutics, Inc. June 25, 2024 Join
MBUU Malibu Boats, Inc. June 28, 2024 Join
GL Globe Life Inc. f/k/a Torchmark Corporation July 01, 2024 Join
EQIX Equinix, Inc. July 01, 2024 Join
ALT Altimmune, Inc. July 05, 2024 Join
AXTI AXT, Inc. July 05, 2024 Join
LI Li Auto Inc. July 09, 2024 Join
SPT Sprout Social, Inc. July 12, 2024 Join
NARI Inari Medical, Inc. July 12, 2024 Join
UNH UnitedHealth Group Inc. July 15, 2024 Join
TDOC Teladoc Health, Inc. July 16, 2024 Join